Related Experiment Videos
Recurrent brief depression: the Zurich Study
1Research Department, Psychiatric University Hospital Zurich, Switzerland.
The Journal of Clinical Psychiatry
|April 1, 1994
Summary
Recurrent brief depression, characterized by short, frequent depressive episodes, affects 5% of the population. This condition significantly impacts work and is linked to increased suicidality and anxiety disorders.
Area of Science:
- Psychiatry
- Epidemiology
- Mental Health Research
Background:
- Manic depressive illness initially encompassed mild depressive and hypomanic states.
- The Zurich Study identified recurrent brief depression (RBD) with major depressive episode severity.
- RBD is now recognized in community and general practice studies.
Purpose of the Study:
- To define and confirm the concept of recurrent brief depression.
- To investigate the prevalence and characteristics of RBD.
- To explore the relationship between RBD, major depression, and comorbid conditions.
Main Methods:
- Longitudinal epidemiologic study (Zurich Study).
- Analysis of diagnostic criteria for RBD: >=5 depressive symptoms, <2 weeks duration, >=12 episodes/year, work impairment.
- Prevalence estimation in general population.
Main Results:
- RBD has a 1-year prevalence of 5% and lifetime prevalence of 16%.
- RBD episodes are brief (1-3 days) but recurrent, meeting major depression symptom severity.
- RBD is associated with significant suicidality, treatment-seeking, and comorbidity with anxiety disorders.
Conclusions:
- Recurrent brief depression is a distinct diagnostic entity with significant public health implications.
- RBD can transition to major depression and vice versa.
- Combined RBD and major depression indicate more severe illness, higher suicide attempt rates, and increased treatment-seeking.